PR > Press Releases

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press Releases

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

2026.07.02
SK bioscience Publishes 2026 ESG Report

2026.06.29
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development

2026.06.09
SK bioscience Hosts Family Day at New Songdo Headquarters

2026.06.01
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund

2026.05.29
SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

2026.05.26
SK bioscience’s Songdo Global R&PD Center Achieves LEED Gold Certification from USGBC

2026.04.30
Global leaders in immunization policy and vaccine manufacturing honored at 2026 IVI-SK bioscience Park MahnHoon Award Ceremony

2026.04.24
SK bioscience Earns MSCI ESG ‘A’ Rating for Third Consecutive Year… Demonstrates ESG Competitiveness Amid Strengthened Global Standards

2026.04.02
SK bioscience and IDT Biologika Partner on Development and Manufacturing of Drug Product for MSD’s Zaire Ebola Vaccine with an Updated Manufacturing Process

2026.03.23
SK bioscience and IVI Announce Recipients of the 2026 ManHoon Park Award, Including U.S. Professor Orenstein

2026.03.19
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

2026.03.18